IMPORTANT DISCLOSURE: FOR NON-US PROFESSIONAL INVESTORS ONLY
This site is intended only for non-US professional investors or US-based fiduciaries representing non-US investors eligible to invest in Aegon Asset Management’s (the “Company”) UCITS funds. This site, and the funds described herein, are not suitable for individual investors.
The following information regarding the Company’s funds is for informational purposes only and does not constitute an offer for shares, products or services and should not be interpreted as an offer to sell, an invitation to acquire an investment, or a solicitation of an offer to buy for any persons who are prohibited from receiving such information under their domiciled local laws.
Aegon Asset Management Investment Company (Ireland) Plc is structured as an umbrella type open-ended investment company with variable capital consisting of a number of different sub-funds (“Funds”) and is authorized in Ireland pursuant to European Communities (Undertakings for Collective Investment in Transferable Securities) UCITS Regulations and the Central Bank UCITS Regulations (“UCITS Regulations"). Aegon Asset Management Europe ICAV is structured as an umbrella type open-ended investment ICAV with variable capital consisting of Funds and is authorized in Ireland as a UCITS pursuant to the UCITS Regulations.
These Funds are registered in Ireland and are available only to residents of those jurisdictions where allowed by law. Investors that do not meet these requirements will be denied access by the Company.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Austria.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
If you are a retail investor, we recommend that you seek qualified financial advice before making any investment decisions.
You can get the current prospectuses, accounts, important information for investors and fund prices at https://www.fundinfo.com. Please click the accept button and select the county in which you live and identify yourself as a private investor.
Risk notice - Capital risk. The value of investments can go down as well as up and is not guaranteed.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Belgium.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
If you are a retail investor, we recommend that you seek qualified financial advice before making any investment decisions.
You can get the current prospectuses, accounts, important information for investors and fund prices at https://www.fundinfo.com. Please click the accept button and select the county in which you live and identify yourself as a private investor.
Risk notice - Capital risk. The value of investments can go down as well as up and is not guaranteed.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Denmark.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Finland.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in France.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
Attention aux fraudeurs se faisant passer pour Aegon Asset Management, d’autres institutions financières et organismes de régulation: Nous avons reçu plusieurs signalements de fraudeurs se faisant passer pour Aegon AM et d’autres entreprises en créant de faux sites web, de fausses publicités et de fausses adresses mail. Pour en savoir plus sur la manière de vous protéger contre ces escroqueries et comment signaler un comportement suspect,veuillez lire ce qui suit.
If you are a retail investor, we recommend that you seek qualified financial advice before making any investment decisions.
You can get the current prospectuses, accounts, important information for investors and fund prices at https://www.fundinfo.com. Please click the accept button and select the county in which you live and identify yourself as a private investor.
Risk notice - Capital risk. The value of investments can go down as well as up and is not guaranteed.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Germany.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
If you are a retail investor, we recommend that you seek qualified financial advice before making any investment decisions.
You can get the current prospectuses, accounts, important information for investors and fund prices at https://www.fundinfo.com. Please click the accept button and select the county in which you live and identify yourself as a private investor.
Risk notice - Capital risk. The value of investments can go down as well as up and is not guaranteed.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Jersey.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Ireland.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Italy.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Luxembourg.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
If you are a retail investor, we recommend that you seek qualified financial advice before making any investment decisions.
You can get the current prospectuses, accounts, important information for investors and fund prices at https://www.fundinfo.com. Please click the accept button and select the county in which you live and identify yourself as a private investor.
Risk notice - Capital risk. The value of investments can go down as well as up and is not guaranteed.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Malta.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in the Netherlands.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
If you are a retail investor we recommend that you take qualified financial advice before making any investment decisions. You can obtain the latest prospectus, accounts, Key Investor Information and fund prices at www.aegon.nl.
Risk Warning Capital at risk. The value of investments may go up or down and is not guaranteed.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Norway.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Portgual.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Spain.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
If you are a retail investor, we recommend that you seek qualified financial advice before making any investment decisions.
You can get the current prospectuses, accounts, important information for investors and fund prices at https://www.fundinfo.com. Please click the accept button and select the county in which you live and identify yourself as a private investor.
Risk notice - Capital risk. The value of investments can go down as well as up and is not guaranteed.
This is a marketing communication. Please refer to the Legal documents of the Fund(s), such as the KIID and/or prospectus, before making any final investment decisions.
I confirm that I am a Professional Investor based in Sweden.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
This Website and all information contained herein is intended for exclusive use of qualified investors as defined in the Federal Act on Collective Investment Schemes of 23 June 2006 (the “CISA”) and in its implementing ordinance, which have their residence or registered office in Switzerland (the “Qualified Investors”), excluding opt up Qualified investors.
Entry to the website is subject to your understanding of certain terms and important information which are available below:
If you are not a Qualified Investor or are an opt up Qualified Investor under CISA with residence or registered office in Switzerland, we recommend you consult a financial adviser before making any investment decisions.
You can get the current prospectuses, accounts, important information for investors and fund prices at https://www.fundinfo.com. Please click the accept button and select the county in which you live and identify yourself as a private investor.
Risk notice - Capital risk. The value of investments can go down as well as up and is not guaranteed.
For investors in Argentina, Chile, Colombia, Peru, and Uruguay:
This material does not constitute an offer of products or securities in any country listed above or in any jurisdiction within Latin America and should not be construed as such. Unless otherwise indicated, no regulator or government authority has reviewed the content or the merits of any products and services referenced or implied herein. This material is being made available only to the extent it is in accordance with the restrictions and/or limitations implemented by any applicable laws and regulations. Information is directed at and intended only for institutional investors and their advisers for informational purposes and may not be reproduced in any form. Before acting on any information provided herein, prospective investors should inform themselves of, and observe, all applicable laws, rules and regulations of any relevant jurisdictions and obtain independent advice if required.
If your country is not listed above, please contact us.
Proteins are frequently called the building blocks of life because they are found literally everywhere: in our cells, bones, muscles, hormones, and enzymes. They are involved in every activity of biological existence. It is thanks to proteins that our body has structure. They help carry the oxygen that reddens our blood; in the form of enzymes they digest our food, synthesize essential substances, and break down waste products; and the chromosomes which pass on our characteristics to our children include protein in their structure. Their importance to all biological life cannot be understated.
Over the past 20 years, we have witnessed remarkable progress in improving our understanding of the human genome, driven by rapid advances in the speed and accuracy of gene sequencing. Today’s high throughput genomic sequencers are a far cry from the ones used on the Human Genome project, which took the best part of 15 years to complete. Today, researchers can have the necessary sequencing done in hours at a cost of $1000.
By contrast, we are yet to see such dramatic disruption take place in the adjacent field of the proteome. The proteome is the complete set of proteins that is - or can be - expressed by a genome, or an organism. In contrast to the human genome, which has recently been mapped out in its entirety, at present, there are still disagreements among researchers as to how many proteins actually exist. Many of the ones we think exist, we have only predicted. The Human Proteome Project (HPP) is attempting to collate and analyse all the data and create a database of all human proteins. The latest version of this database has around 20,000 predicted, of which 16,518 are supported by solid evidence ("confident protein identifications"). Only about one-third of those have had their 3D structures determined experimentally, and in many cases, those structures are only partially known. Having a clear record of all the possible proteins will allow us to improve our understanding of how proteins interact with each other, and the therapeutic targets in an event when a protein is not behaving as it should.
Source: DeepMind
Part of the reason the proteome is such a tough complex to analyse is the way proteins take shape. To get a bit more technical, a protein is a complex structure that consists of either just a few or up to thousands of amino acids. Once the amino acids are in place, the protein “folds” into a complex 3-dimensional shape. Its shape in part dictates how it interacts with other proteins.
Accurately modelling these shapes and interactions is fiendishly complex. Naturally, researchers have been trying to enlist the aid of computer modelling tools to help them predict protein shapes. Every two years, a competition called CASP (Critical Assessment of Structure Prediction) is held to try and accurately model the shape of proteins based on their amino acid structure alone. Computer-software entries are judged against structures of the same proteins determined using experimental methods.
In a stunning leap forward, in 2020, a novel artificial intelligence tool called AlphaFold, developed by Google’s subsidiary DeepMind in London, stunned the scientific community by dominating the CASP competition (see chart above).
Since then, it has gone on to predict the structure of nearly the entire human proteome, along with almost complete proteomes for various other organisms, ranging from mice and maize to the malaria parasite. This year, DeepMind plans to release a total of more than 100 million structure predictions. That is half of all known proteins. Importantly, freely available open-source code for AlphaFold needed for specialists to run their own versions of the tool has now been published, igniting researchers’ interest in the space.
Researchers say the resource has the potential to revolutionize the life sciences. Understanding and correcting improperly folded proteins can hold the key to developing effective treatments of many severe diseases.
Having witnessed a revolution in genetics over the past 20 years, driven by innovative hardware, are we about to see another one in proteome analysis, driven this time by cutting edge software?